Komori
Renascience (4889) · InitiativeFirst stated

Expansion into the healthcare business, including the operation of medical institutions

First written in FY2027-H1. . Latest entry: FY2027-H1.

1entries
1years
0from disclosures
Share on X
How it moved
Same theme, other companies
Entry into the medical business, including the anti-aging and longevity fieldsA theme 1 companies write about · 0 as a headwind · 1 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2027-H1First statedAnnual report

    「With a view to developing a healthcare business in this field, which is expected to offer strong business potential, the company amended part of its Articles of Incorporation at its 27th Annual General Meeting of Shareholders to expressly add to its corporate purposes the operation of medical institutions, the provision of services related to the operation of medical institutions, and other healthcare businesses and consulting services related to such businesses.」

    With a view to developing a healthcare business, including in the anti-aging and longevity fields, the company amended its Articles of Incorporation to add the operation and contracted operation of medical institutions, as well as related consulting services, to its corporate purposes.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Renascience yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Expansion into the healthcare business, including the operation of medical institutions | Renascience Inc. (4889) | Komori